HIV Testing & Womens Attitudes on HIV Vaccine Trials
Completed · Phase 3
Conditions studied: HIV
In brief
The purpose of this study is to test the effects of different persuasive informational messages on rates of rapid HIV testing and willingness to participate in a HIV vaccine clinical trial. Adult African-American, non-Latina White, and Latina women will be recruited. Women will initially be randomized to 4 groups: 1. no message control; 2. 1-sided message that mentions benefits of HIV testing; 3. 2-sided message that acknowledges minor opposition to testing, then refutes the opposition; and 4. 2-sided message that acknowledge stronger opposition to testing, then refutes the opposition. Women will be offered HIV testing, then re-randomized to a similar set of 4 messages related to HIV vaccine trials. There will therefore be 16 groups in total (4 X 4).
Key facts
- Study ID
- NCT00771537
- Run by
- Indiana University
- People needed
- 2031
- Starts
- 2006-11-01
- Expected to finish
- 2011-01-01
- Last updated by the study team
- 2013-07-09
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Female
- 18 years of age or older
- Able to understand English or Spanish
- Able to give informed consent
You may not qualify if…
- Not female
- Under 18 years of age
- Not able to understand English and Spanish
- Unable to give informed consent
Where it is running
- Indiana University Medical Group Clinics — Indianapolis, Indiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.